Indefinite Delivery Contract 36C25222D0028
Award Date 4/1/22
Last Date to Order 3/31/27
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- Veterans Integrated Service Network 2 awarded a single-award indefinite-delivery contract to Cytopath Biopay Lab Inc. on February 13, 2023, with a contract ceiling of $1.8 million for ThyroSequence testing services. Work is performed in New York, New York. The contract provides molecular diagnostic laboratory services, specifically ThyroSeq genetic mutation analysis of thyroid nodules to assess cancer risk and support clinical decision-making for veterans within the VA healthcare system....
- Veterans Integrated Service Network 4 awarded a single-award indefinite delivery contract to Cytopath Biopsy Lab Inc. for laboratory testing services—thyroid (ThyroSeq)—with a ceiling of $372,990.00, effective June 1, 2026. The contract carries no set-aside designation. Place of performance is at the vendor's facility in Rye Brook, New York, supporting the Veterans Integrated Service Network 4 healthcare system. The contract procures molecular diagnostic laboratory testing services using...
- Veterans Integrated Service Network 21 awarded an indefinite-delivery contract to Cytopath Biopsy Lab Inc. on August 7, 2023, with a $500,000 ceiling for ThyroSeq laboratory tests to determine thyroid nodule malignancy in surgical decisions. This is a single-award contract with no set-aside. Performance occurs in San Francisco, California. The contract runs through August 6, 2028, with a base period and options structure. The originating solicitation, posted May 18, 2023 with a May 29, 2023...
- This Indefinite Delivery Contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 2 to Cytopath Biopsy Lab Inc., a for-profit medical laboratory specializing in cancer screening and diagnosis using next-generation genomic sequencing. The contract, valued at $322,400, is for the provision of cytopathology and ThyroSequence genetic testing services to support the VA's cancer screening and diagnosis programs for veterans. Under this IDC, the...
- This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide ThyroSeq molecular diagnostic testing services to support cancer screening and diagnosis programs for veterans. Under this $838,000 single-award IDC, Cblpath will deliver firm fixed price task orders to perform ThyroSeq genetic testing at their facilities in Port Chester, New York and Gobernador Piñero,...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded a blanket purchase agreement to Cytopath Biopsy Lab Inc., doing business as Cblpath, to provide molecular thyroid mutation reference testing services. The solicitation aimed to procure specialized diagnostic testing to help determine if thyroid nodules detected in veterans were benign or malignant. Under the IDV, Cblpath has received four firm fixed price call orders totaling $372,000...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 4 awarded a single award indefinite delivery contract to Cytopath Biology Lab Inc. to provide cytopathology and ThyroSeq testing services. Under the contract, Cytopath Biology Lab Inc. leverages its Cblpath division to conduct diagnostic pathology testing at its laboratory in Lebanon, Pennsylvania. Three firm fixed price delivery orders have been issued against the contract to date, valued at...
- The Department of Veterans Affairs (VA) Veterans Health Administration (VHA) has awarded a Blanket Purchase Agreement (BPA) to Cytopath Biopsy Lab Inc., doing business as Cblpath, for the provision of ThyroSeq genomic classifier tests. Cblpath is a provider of specialized anatomic pathology and molecular diagnostic laboratory services, and has held multiple federal contracts with the VA and Defense Health Agency to deliver ThyroSeq testing to support cancer screening and diagnosis programs for...
- Veterans Integrated Service Network 1 (VISN 1), a civilian component of the Department of Veterans Affairs, awarded a single-award Blanket Purchase Agreement valued at $2.88 million to Cytopath Biopsy Lab Inc. (operating as Cblpath) on September 30, 2021, with a performance period extending through September 29, 2026. The BPA establishes an indefinite delivery vehicle through which VISN 1 procures thyroid testing laboratory services to support cancer screening and diagnostic capabilities...
- This Blanket Purchase Agreement (BPA) was awarded by the U.S. Department of Veterans Affairs (VA), specifically the Veterans Integrated Service Network 6, to Cytopath Biopsy Lab Inc., operating under the trade name Cblpath. The contract, with a total ceiling value of $2,250,313.00, is for the provision of Cytopath's proprietary ThyroSeq genomic testing services to support cancer screening and diagnosis programs for veterans and active military personnel. The BPA includes multiple task orders...
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order 36C25222D0028-36C25222N0360 | Cytopath Biopsy Lab Inc. | $4.2k | 4/1/22 | 3/8/24 | 8/15/24 |